stc-15
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 15, 2022 (NCT05584111)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06975293 | Phase 1/Phase 2 (Phase 2) | May 5, 2025 | Coherus Oncology, Inc., STORM Therapeutics LTD |
| NCT05584111 | Phase 1 | Nov 15, 2022 | STORM Therapeutics LTD |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| STORM Therapeutics LTD | For profit | 2 | 2 | 2 | 2022 |
| Coherus Oncology, Inc. | For profit | 1 | 0 | 1 | 2025 |
2 organizations
Page 1 / 1